$ACU
ACME UNITED CORP

2023 Q1 Form 10-K Financial Statement

#000156459023003422 Filed on March 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $45.84M $44.11M $194.0M
YoY Change 5.78% -3.67% 6.52%
Cost Of Revenue $29.56M $30.03M $130.4M
YoY Change 4.2% 0.98% 11.18%
Gross Profit $16.28M $14.08M $63.56M
YoY Change 8.77% -12.28% -1.92%
Gross Profit Margin 35.52% 31.93% 32.77%
Selling, General & Admin $14.09M $14.11M $57.29M
YoY Change 3.65% 8.51% 10.1%
% of Gross Profit 86.56% 100.18% 90.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $720.0K $1.274M $2.762M
YoY Change -29.82% 12.87% 8.0%
% of Gross Profit 4.42% 9.04% 4.35%
Operating Expenses $14.09M $14.11M $57.29M
YoY Change 3.65% 8.51% 10.1%
Operating Profit $2.188M -$25.70K $6.273M
YoY Change 59.59% -100.84% -50.88%
Interest Expense -$902.0K -$921.5K -$2.076M
YoY Change 195.74% 288.42% 128.61%
% of Operating Profit -41.22% -33.1%
Other Income/Expense, Net -$879.0K $107.6K -$246.4K
YoY Change -44050.0% 493.82% -107.44%
Pretax Income $1.309M -$839.6K $3.662M
YoY Change 22.57% -129.63% -75.87%
Income Tax $319.0K -$242.3K $627.7K
% Of Pretax Income 24.37% 17.14%
Net Earnings $990.0K -$597.2K $3.035M
YoY Change 19.28% -125.59% -77.78%
Net Earnings / Revenue 2.16% -1.35% 1.56%
Basic Earnings Per Share $0.28 $0.86
Diluted Earnings Per Share $0.28 -$0.17 $0.82
COMMON SHARES
Basic Shares Outstanding 3.538M 3.535M 3.528M
Diluted Shares Outstanding 3.541M 3.719M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.764M $6.100M $6.100M
YoY Change -47.92% 25.95% 25.95%
Cash & Equivalents $2.764M $6.100M $6.100M
Short-Term Investments
Other Short-Term Assets $4.960M $3.571M $3.571M
YoY Change 30.18% 35.55% 35.55%
Inventory $58.49M $63.33M $63.33M
Prepaid Expenses
Receivables $32.97M $32.60M $32.60M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $99.18M $105.6M $105.6M
YoY Change -5.03% 10.86% 10.87%
LONG-TERM ASSETS
Property, Plant & Equipment $26.40M $26.42M $29.05M
YoY Change -2.06% 9.94% 6.96%
Goodwill $8.189M $8.189M
YoY Change 70.61%
Intangibles $20.27M $20.79M
YoY Change 20.66%
Long-Term Investments
YoY Change
Other Assets $750.0K $750.0K $750.0K
YoY Change
Total Long-Term Assets $58.28M $58.78M $58.78M
YoY Change 19.83% 19.49% 19.49%
TOTAL ASSETS
Total Short-Term Assets $99.18M $105.6M $105.6M
Total Long-Term Assets $58.28M $58.78M $58.78M
Total Assets $157.5M $164.4M $164.4M
YoY Change 2.87% 13.8% 13.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.60M $10.51M $10.51M
YoY Change -3.13% 17.12% 17.13%
Accrued Expenses $1.216M $10.08M $8.849M
YoY Change -86.39% 1.7% -10.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $405.0K $404.6K $404.6K
YoY Change 4.11% 4.13% 4.13%
Total Short-Term Liabilities $24.03M $22.13M $22.13M
YoY Change 12.42% 9.13% 9.13%
LONG-TERM LIABILITIES
Long-Term Debt $40.14M $49.92M $60.61M
YoY Change -0.04% 51.09% 37.38%
Other Long-Term Liabilities $654.0K $622.4K $2.306M
YoY Change 9.0% 3.91% -2.47%
Total Long-Term Liabilities $40.79M $50.54M $62.92M
YoY Change 0.09% 50.25% 35.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.03M $22.13M $22.13M
Total Long-Term Liabilities $40.79M $50.54M $62.92M
Total Liabilities $77.35M $85.35M $85.35M
YoY Change 2.72% 26.71% 26.71%
SHAREHOLDERS EQUITY
Retained Earnings $71.46M $70.97M
YoY Change 1.73% 1.57%
Common Stock $12.72M $12.70M
YoY Change 0.49% 0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost) $16.00M $16.00M
YoY Change 0.0% 0.0%
Treasury Stock Shares $1.545M $1.545M
Shareholders Equity $80.12M $79.03M $79.03M
YoY Change
Total Liabilities & Shareholders Equity $157.5M $164.4M $164.4M
YoY Change 2.87% 13.8% 13.8%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $990.0K -$597.2K $3.035M
YoY Change 19.28% -125.59% -77.78%
Depreciation, Depletion And Amortization $720.0K $1.274M $2.762M
YoY Change -29.82% 12.87% 8.0%
Cash From Operating Activities $7.676M $10.50M $2.892M
YoY Change -240.1% 385.7% -43.75%
INVESTING ACTIVITIES
Capital Expenditures $701.0K $1.005M $4.304M
YoY Change -235.33% -163.6% -32.46%
Acquisitions $9.622M
YoY Change
Other Investing Activities -$13.39K -$9.622M
YoY Change
Cash From Investing Activities -$701.0K -$1.019M -$14.23M
YoY Change 35.33% -35.55% 123.25%
FINANCING ACTIVITIES
Cash Dividend Paid $497.0K $1.903M
YoY Change 8.52% 6.19%
Common Stock Issuance & Retirement, Net $84.72K
YoY Change -97.26%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.32M -7.878M 14.28M
YoY Change -260.06% 711.91% 598.93%
NET CHANGE
Cash From Operating Activities 7.676M 10.50M 2.892M
Cash From Investing Activities -701.0K -1.019M -14.23M
Cash From Financing Activities -10.32M -7.878M 14.28M
Net Change In Cash -3.336M 1.602M 2.757M
YoY Change -818.97% -511.35% 307.87%
FREE CASH FLOW
Cash From Operating Activities $7.676M $10.50M $2.892M
Capital Expenditures $701.0K $1.005M $4.304M
Free Cash Flow $6.975M $9.493M -$1.413M
YoY Change -240.6% 153.69% 14.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.00415
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
138013594
CY2022 acu Direct Import Sales To Total Net Sales Percentage
DirectImportSalesToTotalNetSalesPercentage
0.08
CY2021 acu Direct Import Sales To Total Net Sales Percentage
DirectImportSalesToTotalNetSalesPercentage
0.09
CY2022 us-gaap Revenues
Revenues
193962000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
6273000
CY2022Q4 us-gaap Assets
Assets
164377000
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
4305000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4578000
CY2021 us-gaap Revenues
Revenues
182088000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Range Of Dividends Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRangeOfDividendsUsed
1.9%
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1803302
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.14
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.63
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1622738
CY2022 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Security12b Title
Security12bTitle
$2.50 par value Common Stock
CY2022 dei Trading Symbol
TradingSymbol
ACU
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022Q2 acu Revenue Milestone Period
RevenueMilestonePeriod
P2Y
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-246396
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0042
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0111
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.00397
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201802Member
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
01-07698
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CT
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-0236700
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Waterview Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Shelton
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06484
CY2022 dei City Area Code
CityAreaCode
203
CY2022 dei Local Phone Number
LocalPhoneNumber
254-6060
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 us-gaap Revenues
Revenues
193962357
CY2021 us-gaap Revenues
Revenues
182087559
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
130403572
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
117287202
CY2022 us-gaap Gross Profit
GrossProfit
63558785
CY2021 us-gaap Gross Profit
GrossProfit
64800357
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57285483
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52030370
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
6273302
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
12769987
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
2396431
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
921965
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
31970
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
13742
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2364461
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-908223
CY2021 acu Ppp Loan Forgiveness
PPPLoanForgiveness
3508047
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-246396
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-194877
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-246396
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3313170
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3662445
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15174934
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
627679
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1519255
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.93
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.45
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-707251
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-554681
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2327515
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13100998
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6100409
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4843349
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
32603463
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34220635
CY2022Q4 us-gaap Inventory Net
InventoryNet
63325206
CY2021Q4 us-gaap Inventory Net
InventoryNet
53552254
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2820935
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2634376
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
750000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
105600013
CY2021Q4 us-gaap Assets Current
AssetsCurrent
95250614
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2087899
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1380648
CY2022Q4 us-gaap Land
Land
1979474
CY2021Q4 us-gaap Land
Land
1761434
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
16614149
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
13455514
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
31491637
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
29760410
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50085260
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
44977358
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23669724
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20949861
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26415536
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24027497
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20790535
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17230529
CY2022Q4 us-gaap Goodwill
Goodwill
8188829
CY2021Q4 us-gaap Goodwill
Goodwill
4799829
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2632191
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3130215
CY2022Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
750000
CY2022Q4 us-gaap Assets
Assets
164377104
CY2021Q4 us-gaap Assets
Assets
144438684
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10514288
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8976629
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1130244
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1000470
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
404588
CY2021Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
388536
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10077542
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9909477
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22126662
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20275112
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49915649
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33037172
CY2022Q4 acu Mortgage Payable Non Current
MortgagePayableNonCurrent
10693612
CY2021Q4 acu Mortgage Payable Non Current
MortgagePayableNonCurrent
11080923
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1683323
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2364236
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
305285
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
599280
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
622441
CY2022Q4 us-gaap Liabilities
Liabilities
85346972
CY2021Q4 us-gaap Liabilities
Liabilities
67356723
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5083051
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3538179
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5065518
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3520646
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12698624
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12654787
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1544872
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1544872
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15995622
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15995622
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13447797
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11930067
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
70967232
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69873377
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
79030132
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
77081961
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
164377104
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
144438684
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
62716443
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-554681
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1806758
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1815554
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3089045
CY2021 acu Adjustments To Additional Paid In Capital Cash Settlement Of Stock Options
AdjustmentsToAdditionalPaidInCapitalCashSettlementOfStockOptions
342285
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1473444
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
77081961
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-707251
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1803302
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1940911
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84715
CY2022 acu Adjustments To Additional Paid In Capital Cash Settlement Of Stock Options
AdjustmentsToAdditionalPaidInCapitalCashSettlementOfStockOptions
108155
CY2022 acu Net Share Settlement Of Stock Options
NetShareSettlementOfStockOptions
218295
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
79030132
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2022 us-gaap Depreciation
Depreciation
2762276
CY2021 us-gaap Depreciation
Depreciation
2557680
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1815508
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1490894
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1803302
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1806758
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-293995
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
489059
CY2022 acu Non Cash Lease Adjustment
NonCashLeaseAdjustment
-42570
CY2021 acu Non Cash Lease Adjustment
NonCashLeaseAdjustment
158250
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
189874
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
199996
CY2021 acu Ppp Loan Forgiveness
PPPLoanForgiveness
3508047
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
7228368
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3209330
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1040319
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1497258
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1528936
CY2021 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-8515101
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5140578
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6372615
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
300000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9622391
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14226655
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6372615
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1698915
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1316938
CY2022 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
16848326
CY2021 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-5729995
CY2022 acu Repayments On Mortgage
RepaymentsOnMortgage
401410
CY2021 acu Repayments On Mortgage
RepaymentsOnMortgage
3177778
CY2021 acu Borrowing On Mortgage
BorrowingOnMortgage
11469459
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
1903346
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
1792356
CY2022 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
108155
CY2021 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
342285
CY2022 acu Payments Of Tax On Net Share Settlement Of Stock Options
PaymentsOfTaxOnNetShareSettlementOfStockOptions
243463
CY2021 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1473444
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84715
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3089045
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14276667
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2042646
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-184691
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-134636
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2757060
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
675973
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4843349
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4167376
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7600409
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4843349
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
978378
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
874996
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2124144
CY2021 us-gaap Interest Paid Net
InterestPaidNet
908781
CY2022 acu Business Acquisition Contingent Consideration
BusinessAcquisitionContingentConsideration
1330000
CY2022 acu Non Cash Or Part Non Cash Dividends Accrued Not Paid
NonCashOrPartNonCashDividendsAccruedNotPaid
495406
CY2021 acu Non Cash Or Part Non Cash Dividends Accrued Not Paid
NonCashOrPartNonCashDividendsAccruedNotPaid
457745
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Operations</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The operations of Acme United Corporation (the “Company”) consist of three reportable segments. The operations of the Company are structured and evaluated based on geographic location. The three reportable segments operate in the United States (including Asian operations), Canada and Europe. Principal products across all segments are first aid kits and medical products, scissors, shears, knives, rulers and pencil sharpeners, which are sold primarily to wholesale, contract and retail stationery distributors, office supply super stores, mass market retailers, industrial distributors, school supply distributors, drug store retailers, sporting goods stores, hardware chains and wholesale florists.</p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Estimates<span style="font-style:normal;"> – The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most sensitive and significant accounting estimates relate to customer rebates, valuation allowances for deferred income tax assets, obsolete and slow-moving inventories, potentially uncollectible accounts receivable, intangibles and stock-based compensation. Actual results could differ from those estimates.</span></p>
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
305285
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2012133
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1921376
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1919183
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1651089
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-288191
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-239753
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1060812
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1007187
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P9Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1322225
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
664766
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
870739
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
922244
CY2022 acu Cost Of Goods And Services Sold Shipping And Handling
CostOfGoodsAndServicesSoldShippingAndHandling
11328276
CY2021 acu Cost Of Goods And Services Sold Shipping And Handling
CostOfGoodsAndServicesSoldShippingAndHandling
10071710
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1563477
CY2021 us-gaap Advertising Expense
AdvertisingExpense
976268
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration<span style="font-style:normal;"> – The Company performs ongoing credit evaluations of its customers and generally does not require collateral for the extension of credit. Allowances for credit losses are provided and have been within management's expectations. The Company had two customers in 2022 and 2021, that individually exceeded 10% of consolidated net sales. Net sales to these customers were approximately 15% and 10% of consolidated net sales in 2022 and 17% and 11% in 2021.</span></p>
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1029656
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-238408
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
401196
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
45371042
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
40412875
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
408346
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
88847
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
17545818
CY2021Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
13050532
CY2022Q4 us-gaap Inventory Net
InventoryNet
63325206
CY2021Q4 us-gaap Inventory Net
InventoryNet
53552254
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1720350
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1554217
CY2022Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
10007698
CY2021Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
7994698
CY2022Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
18502207
CY2021Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
16066973
CY2022Q4 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
1247536
CY2021Q4 us-gaap Finite Lived Noncompete Agreements Gross
FiniteLivedNoncompeteAgreementsGross
320256
CY2022Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
379921
CY2021Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
379921
CY2022Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2271980
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2271980
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
32409342
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
27033828
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11618807
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9803299
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20790535
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17230529
CY2022Q4 us-gaap Goodwill
Goodwill
8188829
CY2021Q4 us-gaap Goodwill
Goodwill
4799829
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
28979364
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
22030358
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1815508
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1490894
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-56157
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
88403
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-294565
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
489599
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
627679
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1519255
CY2022Q4 acu Accrued Customer Rebates
AccruedCustomerRebates
5533802
CY2021Q4 acu Accrued Customer Rebates
AccruedCustomerRebates
5413829
CY2022Q4 acu Accrued Contingent Liability Current And Noncurrent
AccruedContingentLiabilityCurrentAndNoncurrent
1330000
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
791231
CY2021Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1585938
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
495406
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
457745
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
533746
CY2021Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
564172
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
2015798
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1887793
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10699983
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
9909477
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
426594
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
419298
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
65263
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4980
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
192215
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
153937
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
588961
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
333883
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-142095
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
9721756
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
3804540
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5453178
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3662445
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15174934
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
716122
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2915698
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
120922
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
115855
CY2022 acu Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
-128169
CY2021 acu Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
-1508877
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-81196
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-3421
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
627679
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1519255
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1400000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2004200
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1916218
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2004200
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1916218
CY2022Q4 acu Deferred Tax Assets Asset Valuations
DeferredTaxAssetsAssetValuations
1109954
CY2021Q4 acu Deferred Tax Assets Asset Valuations
DeferredTaxAssetsAssetValuations
983055
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
1200000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
599280
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3900000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
50000000000
CY2022Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
15000000000
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2022Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
160365
CY2022 acu Revenues Disaggregation By Category
RevenuesDisaggregationByCategory
193962000
CY2021 acu Revenues Disaggregation By Category
RevenuesDisaggregationByCategory
182088000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
12770000
CY2021Q4 us-gaap Assets
Assets
144439000
CY2021 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
6373000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4049000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
6273000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
12770000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2364000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-908000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3313000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3662000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15175000
CY2022 us-gaap Revenues
Revenues
193962000
CY2021 us-gaap Revenues
Revenues
182088000
CY2022 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
108155
CY2021 acu Payments Related To Cash Settlement Of Share Based Compensation
PaymentsRelatedToCashSettlementOfShareBasedCompensation
342285
CY2022 acu Issue Of Shares Related To Settlement Of Share Based Compensation
IssueOfSharesRelatedToSettlementOfShareBasedCompensation
10067
CY2021 acu Issue Of Shares Related To Settlement Of Share Based Compensation
IssueOfSharesRelatedToSettlementOfShareBasedCompensation
7726
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1537052
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1487925
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
133250
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
299750
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6562
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5525
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
46068
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
245098
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1617672
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1537052
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1132174
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
971568
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
166750
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
18650
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
29.35
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
38.38
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
31.50
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
23.01
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.73
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.15
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.30
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.60
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.83
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.33
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1617672
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1132174
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0279
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.00413
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Range Of Dividends Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRangeOfDividendsUsed
1.3 - 1.8%
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1806758
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3599153
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15436026
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1565553
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12128507
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
747730
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6582918
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3034766
CY2021 us-gaap Net Income Loss
NetIncomeLoss
13655679
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3527626
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3471374
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
191624
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
483861
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3719250
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3955235
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.93
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.45
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
296438
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
229250
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-825967
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-554681
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1380648
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-707251
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2087899
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6100000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4843000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
750000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
750000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7600000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4843000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1239000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1265000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1281000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1098000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
545000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1760000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1239000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
918000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
691000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
155000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3003000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
190000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1130000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1683000
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2022 dei Auditor Firm
AuditorFirmId
688

Files In Submission

Name View Source Status
acu-20221231_def.xml Edgar Link unprocessable
acu-20221231_cal.xml Edgar Link unprocessable
acu-20221231_pre.xml Edgar Link unprocessable
0001564590-23-003422-index-headers.html Edgar Link pending
0001564590-23-003422-index.html Edgar Link pending
0001564590-23-003422.txt Edgar Link pending
0001564590-23-003422-xbrl.zip Edgar Link pending
acu-10k_20221231.htm Edgar Link pending
acu-20221231.xsd Edgar Link pending
acu-ex21_6.htm Edgar Link pending
acu-ex231_10.htm Edgar Link pending
acu-ex311_9.htm Edgar Link pending
acu-ex312_8.htm Edgar Link pending
acu-ex321_11.htm Edgar Link pending
acu-ex322_7.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
acu-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
acu-10k_20221231_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending